Sulfonamide substituted indolinones as inhibitors of DNA dependent protein kinase (DNA-PK)
申请人:Sugen, Inc.
公开号:US20040266843A1
公开(公告)日:2004-12-30
The present invention relates generally to the field of radiosensitizing agents which are capable of enhancing radiotherapy by inhibiting DNA-PK (DNA-protein kinase). In particular, it relates to sulfonamide substituted indolinones which inhibit DNA-PK.
3-methylidenyl-2-indolinone modulators of protein kinase
申请人:Sugen, Inc.
公开号:US20040024010A1
公开(公告)日:2004-02-05
The present invention relates to novel 3-methylidenyl-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.